BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma.
Pyogenic granuloma (PG) is a common benign vascular skin lesion presenting as a rapidly growing angiomatous papule. The pathogenesis of most sporadic PG and PG associated with port wine stains (PWS) remains elusive. We report that of 10 PG secondarily arisen on a PWS, 8 showed a BRAF c.1799T>A (p.(Val600Glu)) and 1 a NRAS c.182A>G (p.(Gln61Arg)) mutation. The GNAQ c.548G>A mutation was identified in the PG and in the respective underlying PWS, indicating that the PG originate from cells of the PWS. In contrast to PG, twelve papulonodular lesions, which had developed in the PWS of seven patients, showed a RAS and BRAF wildtype status. In sporadic PG we identified the BRAF c.1799T>A mutation in 3/25, a BRAF c.1391G>A mutation in 1/25 and a KRAS c.37G>C mutation in 1/25. Mutation-specific immunohistochemical detection of BRAF p.(Val600Glu) confirmed endothelial cells as carriers of the mutation in secondary and sporadic PG. Our study identifies the BRAF c.1799T>A mutation as a major driver mutation in the pathogenesis of particularly secondary PG. These data shed light on the hitherto undetermined genetic basis of PG and classify PG as a benign neoplasm.Journal of Investigative Dermatology accepted article preview online, 29 September 2015. doi:10.1038/jid.2015.376.